Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Goodwill: 2017-2025

Historic Goodwill for Ultragenyx Pharmaceutical (RARE) over the last 8 years, with Sep 2025 value amounting to $44.4 million.

  • Ultragenyx Pharmaceutical's Goodwill changed negligibly% to $44.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.4 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $44.4 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Ultragenyx Pharmaceutical's Goodwill stood at $44.4 million, which was down 0.00% from $44.4 million recorded in Q2 2025.
  • Ultragenyx Pharmaceutical's Goodwill's 5-year high stood at $44.4 million during Q1 2021, with a 5-year trough of $44.4 million in Q1 2021.
  • In the last 3 years, Ultragenyx Pharmaceutical's Goodwill had a median value of $44.4 million in 2025 and averaged $44.4 million.